Some thought the breakthrough was a “Holy Grail.” Actually, it was a fraud that betrayed patients, ruined careers, and ...

The Organization for Associate Degree Nursing (OADN) has named Sami Rahman, Director of Simulation and Clinical Laboratories for the Blinn College District, to its prestigious 2025 class of fellows of ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

MONTGOMERY, Texas — A Montgomery High School graduate is alive today thanks to his mother’s quick decision to take him to the emergency room after noticing what seemed like minor symptoms. That visit ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

A human trial showed promising results for the ELI-002 2P, which successfully targeted colorectal and pancreatic cancer tumors.

Radiation therapy may account for half of all new cancers among the growing population of childhood cancer survivors, according to a study published Aug. 11 in the Journal of Clinical Oncology. With ...

The FDA has granted accelerated approval to Hernexeos for the treatment of adults with unresectable or metastatic non-squamous NSCLC.

Aprea Therapeutics ( (APRE) ) has issued an announcement. On August 12, 2025, Aprea Therapeutics reported its financial results for the second quarter ending June 30, 2025, and provided a clinical ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results in patients with pancreatic and colorectal cancer ...

Published scientific research fuels the breakthroughs that shape our world — but what happens when that research is totally ...